Highly targeted spatiotemporal interventions against cholera epidemics, 2000-19: a scoping review. by Ratnayake, Ruwan et al.
1 
 
Highly-targeted spatiotemporal interventions against cholera epidemics, 2000-2019: a 
scoping review 
 
Ruwan Ratnayake MHS1,2, *, Flavio Finger PhD1,2,3, Andrew S. Azman PhD4,5,6, Daniele 
Lantagne PhD7, Sebastian Funk PhD1,2, Prof. W. John Edmunds PhD1,2, Prof. Francesco Checchi 
PhD1 
 
1 Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical 
Medicine, London, UK 
2 Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and 
Tropical Medicine, London, UK 
3 Epicentre, Paris, France 
4 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, 
MD, USA 
5 Center for Humanitarian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, 
MD, USA 
6 Médecins Sans Frontières, Geneva, Switzerland 
7 Department of Civil and Environmental Engineering, Tufts University, Medford, MA, USA 
 
*Corresponding author: 
Ruwan Ratnayake, Department of Infectious Disease Epidemiology, London School of Hygiene 













Key points (Panel) 
 
1. Case-area targeted intervention (CATI) for cholera is based on the premise that early cluster 
detection can trigger a rapid, localised response in the high-risk radius around one or several 
households to reduce transmission sufficiently to extinguish an outbreak or reduce its spread.  
 
2. There is moderate evidence that antibiotic chemoprophylaxis, single-dose oral cholera 
vaccination, intensive hygiene promotion, and point-of-use water treatment present effective 
mechanisms of action for rapidly limiting transmission in the household and its high-risk 
radius.  
 
3. A high-risk spatiotemporal ring of 50 to 100 metres across 7 days in urban and rural contexts, 
specifies an appropriate implementation radius. This is likely due to intense household 
transmission and shared risk factors among neighbouring households.  
 
4. Two controlled evaluations of CATI in Haiti and Bangladesh demonstrated respectively a 
reduction in the size of case-clusters, and infection among household contacts, and 
uncontrolled evaluations in Cameroon and the Democratic Republic of Congo suggested 
reductions in transmission.  
 
5. While CATI shows promise for outbreak control, it is critically-dependent on early detection 




Search strategy and selection criteria (Panel) 
We searched the PubMed, EMBASE, and Cochrane Databases for articles published from 
January, 2000, to April 23, 2020, with the following terms in the title or abstract:  
▪ (“cholera” or “Vibrio cholerae”, or “acute watery diarrhea”) and, 
▪ (“effect” or “efficacy” or “protect”) and (“antibiotic” or “antimicrobial” or 
“chemoprevention” or “chemoprophylaxis”) or “vaccine” or (“hygiene promotion” or “health 
education” or “hand hygiene” or “hand washing” or “hand disinfection” or “health 
behaviour”) or (“water purification” or “water treatment” or “chlorination” or “Aquatab” or 
“well chlorination” or “bucket chlorination” or “pot chlorination”)* or (“spraying” or 
“household spraying” or “household cleaning”)* or (“funeral” or “burial” or “corpse”)*,ⱡ or, 
▪ (“communicable disease transmission” or “disease clustering” or “clustering” or “spatial 
analysis” or “spatial transmission” or “spatio-temporal analysis” or “household transmission” 
or “community transmission” or “neighborhood transmission” or “hotspot”) or,  
▪ (“targeted response” or, "targeted intervention" or “comprehensive targeted response" or 
“case-area targeted response" or "case-area targeted intervention” or "alert and response" or 
"rapid response" or "ring vaccination" or "community response" or "community-based 
response" or “community health workers” or community health volunteer) 
 
*The requirement for effectiveness studies was removed since none were initially found; ⱡ Date 
limits were removed as no relevant articles were initially found.  
 
Unpublished reports on case-area targeted intervention were sought by searching agency 
websites and contacting experts in cholera response. We checked reference lists of retrieved 







Globally, cholera epidemics continue to challenge disease control. Although mass campaigns 
covering large populations are commonly used to control cholera, spatial-targeting of case-
households and their radius is emerging as a potentially efficient strategy. We conducted a 
scoping review to investigate the effectiveness of interventions delivered through case-area 
targeted intervention (CATI), its optimal spatiotemporal scale, and its effectiveness in reducing 
transmission. Fifty-three articles were retrieved. We found that antibiotic chemoprophylaxis, 
point-of-use water treatment, and hygiene promotion can rapidly reduce household transmission, 
and single-dose vaccination could extend the duration of protection within the radius of 
households. Current evidence supports a high-risk spatiotemporal zone of 100-meters around 
case-households, for 7 days. Two evaluations separately demonstrated reductions in household 
transmission when targeting case-households, and in size and duration of case-clusters when 
targeting radii. While CATI shows promise for outbreak control, it is critically-dependent on 
early detection capacity and requires prospective evaluation of intervention packages. 





In Africa and the Middle East, 126 million people live in cholera hotspots where outbreaks 
recur.1,2 From 2017 to 2018, the largest epidemics (range, 16,000 to 1.3 million reported cases) 
occurred during humanitarian crises in Yemen, Democratic Republic of Congo (DRC), Somalia, 
Northern Nigeria, and South Sudan.3,4 Rapid spread is driven by inadequate access to water, 
sanitation and health services, poor hygiene practices, weak surveillance and response, 
population displacement and overcrowding, and compromised immunity due to malnutrition.5-8 
This results in large at-risk populations, and challenging epidemic responses. 
Mass, community-wide campaigns, in which multi-sector interventions cover large 
administrative areas thought to be at-risk for infection (e.g., cities), are commonly used to control 
cholera outbreaks. To prevent spatial propagation, control strategies could focus on containing 
clusters. Case-area targeted intervention (CATI) is based on the premise that early cluster 
detection can trigger a rapid, localised response in the high-risk radius around one or several 
households to reduce transmission sufficiently to extinguish the outbreak or reduce its spread. 
Similar logic underpinned ring vaccination of close contacts to control smallpox in the 1970s and 
Ebola more recently.9,10 Comparatively, cholera containment must address both person-to-person 
and environmentally-mediated transmission routes. Outbreaks are driven by a rapid cycle of 
household transmission, due to a short incubation period (estimated median, 1·4 days), bacterial 
shedding of several days to two weeks, and resulting contamination of water, food, and 
fomites.11-14 Estimates of the proportion of the effective reproduction number (RE, the average 
number of secondary infections per case) due to person-to-person transmission as compared to 
environment-to-human transmission were 45·4% (Haiti) and 82·7% (Zimbabwe).15 CATI’s 
ability to rapidly interrupt both routes is key to reducing RE.  
 In 2017, the Global Task Force on Cholera Control (GTFCC) proposed a strategy which 
emphasized the use of rapid response teams (RRT) who use CATI together with early detection 
to substantially reduce transmission by 2030.1 However, the key parameters for CATI 
implementation (e.g., intervention mix, timeliness, geographical scale) are not well-studied. We 
conducted a scoping review to identify the evidence available and critically review the potential 
for CATI to reduce transmission during outbreaks. We had three objectives. First, we 
investigated evidence on the effectiveness and feasibility of interventions to rapidly limit 
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transmission via person-to-person and environmentally-mediated sources. Second, we 
investigated the spatiotemporal dimensions of transmission to outline CATI’s appropriate spatial 
scale and timing. Third, we evaluated CATI’s feasibility and effectiveness during epidemics. 
METHODS 
The review followed the Preferred Reporting Items for Systematic Review and Meta-Analyses 
Extension for Scoping Reviews (PRISMA-ScR) guidelines.16  
Search strategy and selection criteria  
Separate searches were conducted for each objective. For objective 1 (interventions), meta-
analyses, systematic reviews, and studies of the impact of health and water, sanitation, and 
hygiene (WASH) interventions which primarily aim to reduce transmission at the household or 
community-level were retrieved (Table 1). For objective 2 (spatiotemporal risk), studies 
providing estimates of spatiotemporal scales of transmission were found. For objective 3 (CATI), 
reports and evaluations of CATI implementation during outbreaks were sought. We defined 
CATI as any control strategy where upon detection of a cholera case(s), a team immediately 
targeted interventions to people or households living within a geographic area (often based on 
distance) around these cases. For objective 1, if effect estimates from a meta-analysis were 
unavailable, we used experimental, quasi-experimental, or observational studies describing a 
reduction in incidence using relative risk (RR). For objective 3, we included evaluations with 
effect estimates, and/or population coverage measured through a household survey or 
administrative data. Studies published in English or French between January, 2000 and April 24, 
2020 were included.   
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Table 1. Health and WASH interventions to reduce V. cholerae transmission, by place of delivery 
 
 Household or community  Health facilities 
WASH 
 
Point-of-use water treatment*  
Community water treatment 
Safe water storage* 
Household spraying* 
Hygiene promotion and handwashing  
Disinfection of corpses 
 
*Often delivered through hygiene kits which may include 
chlorine tablets, soap, bleach for disinfection, and/or hygiene 
promotion materials. 




Antibiotic chemoprophylaxis of household contacts 
Oral cholera vaccination 
Supportive care 
Isolation and hospitalization 




The PubMed, EMBASE, and the Cochrane Review Library databases were searched (search 
strings are listed in appendix p 1-3). Unpublished reports on CATI were sought using searches of 
agency websites and by e-mailing 40 experts in cholera response (appendix p 4). Ratnayake 
conducted the literature searches and screening.  
Data abstraction 
For objective 1, RR (and uncertainty intervals) of infection or exposure were extracted and 
converted to a RR reduction (1-RR). Information on the feasibility of rapid application at the 
household and/or community level was documented. For objective 2, spatial (in meters) and 
temporal dimensions (in days) and RR (and uncertainty intervals) were extracted. For objective 
3, operational data on resources, procedures, and costs were extracted (see list in appendix p 5). 
For evaluations, study objectives, design, sample size, RR or odds ratios (OR, and uncertainty 
intervals), and coverage indicators were extracted. The quality of evaluations was assessed using 
a Cochrane Collaboration Risk of Bias tool (e.g., selection bias, confounding, spillover and 
contamination, incomplete outcomes, and selective reporting) (appendix p 9).17 
Conceptual framework   
We developed a conceptual framework to integrate the findings into a pathway for rapidly 
reducing transmission within the ring. We integrated evidence on the optimal spatiotemporal 
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window and positioning of interventions at the primary case-household(s), adjacent households 
and ring according to the speed and magnitude of biological effect, and the logistical burden.   
Role of the funding source 
The funder of the study had no role in study design, data collection, data analysis, data 
interpretation, or writing of the report. The corresponding author had full access to all the data in 
the study and had final responsibility for the decision to submit for publication. 
RESULTS 
Across searches, 3,601 records were retrieved. After de-duplication and screening titles for 
relevance, 2,698 and 56 records remained, respectively. Screening by abstract yielded 41 articles. 
After reviewing reference lists and reports sent from experts, 12 studies were added (9 articles 
from reference lists, 2 abstracts, and one UNICEF report). In total, 53 articles met inclusion 
criteria for objective 1 (n=28)18-45, objective 2 (n=10)46-55, and objective 3 (n=15)56-70 (appendix 
p 6-8). 
Interventions to rapidly limit transmission 
We summarized the potential for interventions to rapidly limit transmission, their estimated 
effectiveness, and potential delivery approaches through CATI (Table 2). 
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Table 2. Theoretical effects on transmission of CATI interventions   
Intervention description, objectives, and potential delivery approach through CATI Theoretical effect (host) 
Antibiotic chemoprophylaxis (ACP) 
ACP acts to rapidly clear V. cholerae among infected persons or protect against infection among uninfected persons. ACP can therefore achieve multiple goals by 
addressing multiple hosts: rapidly protecting uninfected household contacts at risk of infection, and reducing symptom development and shedding among infected 
persons.21,61,63 ACP has been delivered as single-dose doxycycline. The GTFCC only recommends selective ACP for closed populations at high risk of infection 
(e.g. prisons).71 Doxycycline is recommended as first line and azithromycin as second line due to resistance to multiple antibiotics.71  





Oral cholera vaccination (OCV) 
 
Two killed oral cholera vaccines (kOCV), specific to O1 and O139 V. cholerae, are available from the global OCV stockpile (Shanchol and Euvichol). Given the 
limited stock of OCV, a single dose of kOCV can be used strategically during outbreaks to achieve rapid protection among a large population.72 One dose of OCV 
delivered to the ring could protect against further generations of disease in the ring, thus preventing community transmission. Shanchol can be kept in a controlled 
cold chain (or at ambient temperature on the day of vaccination) without affecting safety or effectiveness.73 kOCVs do not require a buffer. OCV requires 
substantial logistical inputs and campaigns are frequently supported by non-governmental organizations.28 
Reduce susceptibility  
(uninfected host) 
Point of use water treatment in household (POUWT) delivered to the household 
 
POUWT, in the form of disinfectant (e.g., chlorine) tablets or liquid, aims to reduce the concentration of V. cholerae in water. One tablet can treat a container of 
water which can be used after 30 minutes.40 Delivery to ring households may avoid recontamination of water in the household by soiled hands.40 POUWT may be 
routinely delivered to households before the outbreak begins, as a preventative measure against a wide spectrum of diarrhoeal diseases. POUWT requires 
education on appropriate use and promotion given taste and odour changes and difficulties in achieving an appropriate concentration.   
Reduce bacterial concentration 
(household water) 
Water treatment of local collection sources 
 
Water treatment of local collection sources aims to reduce the bacterial concentration of V. cholerae at the source of collection. Some sources, for example wells, 
have shown a poor ability to maintain chlorine concentration.36,38 Water from a treated local source is at-risk of re-contamination. Therefore, where possible, 
providing a narrow-necked container for safe transportation and storage is optimal  
Reduce bacterial concentration 
(local collection source) 
Safe storage of treated water  
 
Safe storage and transport of water using narrow-neck containers aims to prevent faecal contamination of treated water by soiled hands during transport from the 
source or storage in the household.36 A container can be delivered with POUWT and/or treatment of local water sources, as biofilms shielding cholera are difficult 
to remove.74  
Facilitate reduction of bacterial 
concentration (household water) 
Household spraying   
 
Household spraying aims to reduce contamination on surfaces. While it lacks evidence for reducing contamination or reducing transmission, it is often carried out 
during outbreaks.36 An alternative to household spraying is distribution of a hygiene kit wherein the household members can use the bleach to repeatedly disinfect 
surfaces. 
Reduce bacterial concentration 
(household surfaces and fomites) 
Hygiene promotion 
 
Hygiene promotion aims to improve knowledge of infection prevention. It encourages behaviour change to facilitate handwashing, use of safe water and safe food 
handling measures, and excreta disposal practices. Intensive hygiene promotion at case-households can be undertaken by a hygiene promoter once or repeatedly 
over a short time period. It is optimally facilitated by providing persons with access to treated water, safe storage, and soap to facilitate actions.60 Mass messaging 
in the community can be undertaken through hygiene promoters delivering messages on water treatment, safe food handling and sanitation, and infection 
prevention through community events and radio messages.67 
Reduce susceptibility  
(uninfected host) 
 
Disinfection of corpses 
 
The corpses of infected persons are disinfected with chlorine to prevent leakage of infectious fluids.45 Additional measures should be undertaken to promote safe 
food handling and hand-washing during funeral gatherings. 
Facilitate reduction in 
susceptibility through safe corpse 





Effectiveness and potential delivery through CATI 
We summarized estimates of effect sizes, delay to onset of effects, and duration of effects for 
interventions (Table S1, appendix p 10). For ACP, a 2011 meta-analysis of different antibiotics 
(tetracycline, doxycycline, ciprofloxacin, sulfadoxine) administered to contacts estimated its 
effectiveness against culture-confirmed infection as 66% (95% CI 34—82).19 During an outbreak 
in Nairobi, Kenya in 2015, a cohort study of doxycycline given to household contacts found a 
similar effectiveness estimate against diarrhea (68%, 95% CI 29—87) (Grandesso, 
unpublished).21 The effectiveness of ACP in preventing symptoms among infected persons has 
been estimated as 96% (95% CI 70—99) with a 2·74 day (95% CI 3·1—2·4) mean reduction in 
shedding duration.18-20,57,75,76 ACP’s effects are short-lived. Doxycycline’s half-life is estimated 
as 20 hours and a single-dose of azithromycin can maintain a concentration adequate to eliminate 
V. cholerae for two days.18,77,78 V. cholerae’s antibiotic resistance patterns change frequently. 
Circulating strains from recent epidemics in DRC, Haiti, Nepal, Tanzania, Yemen, and Zambia 
have shown susceptibility (doxycycline62,79,80, azithromycin79, tetracyclines80,81), fluctuating 
resistance (ciprofloxacin80,82,83, cotrimoxazole80,82, ampicillin81,82), and complete resistance 
(nalidixic acid81-84) to common antibiotics. Doxycycline resistance was not detected among 
cholera cases when ACP was used in Cameroon (2004) and Haiti (2015-7).61,63,66 While no 
updated trial using a particular antibiotic class is available, meta-analysed evidence across 
classes suggests that ACP, for which several antibiotics remain sensitive, can provide immediate 
protection among household contacts. Antibiotics can be stockpiled locally, and a single, oral 
dose can be administered by non-clinical staff.  
WHO recommends using a single dose of killed-OCV (kOCV) during outbreaks where 
the supply of OCV is constrained and resources limited to cover a larger proportion of the 
population in the short-term.29,72 Twelve-month effectiveness is similar for single-dose (69%, 
95% CI 15—65) and two-dose (83%, 95% CI 70—91) regimens, but neither show adequate 
protection for children under five years.24,26,27,31,33 High single-dose effectiveness at two-months 
were found during outbreaks among an immunologically-naïve population in Lusaka, Zambia 
(89%, 95% CI 43—98) and, among a population exposed to cholera a year prior in Juba, South 
Sudan (87%, 95% CI 70—100; includes indirect effects) where a single dose may have acted as 
a booster after exposure.24,25,30  Peak vibriocidal antibody response occurs 7-11 days post-
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administration.24,85  While single-dose kOCV may prevent transmission minimally during the 
first week, it could offer longer protection during subsequent generations of transmission in the 
ring as compared to other interventions. Shanchol is approved to be kept out of the cold chain for 
up to 14 days without exceeding 40°C, allowing staff to pack more vaccine to cover more 
persons per day (Euvichol is expected to be approved soon).73,86,87 
Concerns are commonly raised about the equitable distribution of limited vaccines, 
feasibility of campaigns during humanitarian crises, and concerns of offsetting WASH activities, 
as demonstrated by delays in use in Haiti (2011), South Sudan (2014), and Yemen 
(2017).22,23,28,29,34 However, with the addition of Euvichol and increased manufacturing capacity, 
vaccine supply is expected to triple current levels by 2030.88,89 In 2017, rapid recognition of the 
outbreak in Lusaka and a detailed epidemiological assessment initiated a one-dose reactive 
campaign within two months of the first reported case.32 From 2013 to 2018, the median time 
from approval of vaccination by the global OCV stockpile and arrival in-country was 13 days 
(range, 4—24 days) and from arrival to the start of campaign was 15 days (range, -2—87 
days).90 To support CATI’s rapid response, these timelines emphasize the need to have 
accessible OCV stocks already in-country, and preparedness plans.29  
WASH interventions reduce the risk of exposure to V. cholerae by increasing water 
quantity and quality, isolating faeces, promoting hygiene awareness, and disinfecting surfaces.38 
Two systematic reviews of WASH interventions for cholera cited few studies, and low to 
moderate evidence of impact.36,38 In a meta-analysis of WASH interventions for diarrhea, the 
effectiveness of POUWT and source water treatment in preventing diarrhea was estimated as 
26% (95% CI 15—35) and 11% (95% CI -90—58), respectively (while noting the likely 
attenuation of uptake outside of an outbreak).35 Use of POUWT for cholera was highly-variable 
(range, 7—87%) in DRC, Haiti, Kenya, Nepal, South Sudan, and Zimbabwe, with prior 
familiarity with products and hygiene promotion by community health workers (CHW) 
influencing uptake.40 Water treatment at collection sources may prevent re-contamination during 
transport. To maintain protection of treated water in the household, the use of narrow-neck 
containers is optimal.40 A randomized controlled trial (RCT) of narrow-neck container without 
POUWT showed inconclusive protection against diarrhea of 21% (-0.03—38).35,39 A meta-
12 
 
analysis of case-control studies provided evidence of decreased odds of cholera infection when 
using safe storage (OR 0·55, 95% CI 0·39—0·8).37  
Hygiene promotion of hand-washing and safe food handling is considered a critical step 
alongside water treatment to break transmission from soiled hands regardless of vaccination 
status.42 Soap distribution and hygiene promotion permitted increased self-efficacy, risk 
perception, and an enabling social context to increase hygienic behaviours among cholera-
affected populations in Chad (through self-report) and Bangladesh (observed).36,41,58 There is 
currently no evidence for the effectiveness of household spraying on the reduction of household 
contamination.36,38 Preliminary results from of an exploratory study found that spraying chlorine 
solution on household surfaces (e.g. dirt walls) until visibly wets lead to a rapid reduction of V. 
cholerae 30 minutes post-spraying, which was sometimes followed by re-contamination 
(Gallandat, unpublished).43 Alternatively, hygiene kits provide cleaning materials for ongoing 
disinfection.38,44 For the disinfection of corpses, an increased attack rate following a funeral was 
observed among villages in Guinea-Bissau that did not practice disinfection, compared with 
those that did (RR 2·6, 95% CI 1·9—3·8).45  
While WASH interventions for cholera are under-researched, there is substantial 
knowledge about improving rapid uptake using simple interventions that can be rapidly 
deployed, improving preparedness, and facilitating delivery through CHWs.38,40 CATI is well-
positioned to improve uptake by providing local support to households.  
Determining the spatiotemporal scale of elevated infection risk 
We summarized studies that evaluated the risk of infection among persons exposed to suspected 
cholera cases within spatiotemporal (or spatial-only) windows (e.g., within 25-metres of the 
primary case household, 3 days after onset), compared to any other person in the population 
outside this window (Table S2, appendix, p 11).46-55  
Spatial-only studies demonstrated increased risk extending to ≤150-metres in Kolkata and 
500-metres in Matlab.47 In urban Kalemie, DRC and N’Djamena, Chad, within a 5-day period 
after the primary case visited a health facility, a gradient of elevated risk (RR>1) extended from 
20-metres (RR>20, commensurate with the household and its immediately-surrounding area) to a 
threshold of 220-metres and 330-metres, respectively.49 A re-analysis of data from an OCV 
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cluster RCT in Kolkata, India, limited to maximum 55-metre radii around index cases, found a 
gradient of elevated risk during 7 days up to a threshold of 50-metres (RR 2·5, 95% CI 1·7—3·8) 
and the highest risk within 25-metres (RR 4·8, 95% CI 2·8—8·8) of the primary case.46  The 
elevated risk decreased after 7 days and 100-metres in N’djamena and Kalemie, and 14 days in 
Kolkata.46,49 In rural Matlab, Bangladesh, an analysis of cohorts of primary cases and uninfected 
controls, using increments of 50-metres, found a gradient of elevated risk up to 400-metres, 6 
days after a primary case visited a health facility (RR 1·5, 95% CI 1—2·1).51 High risk existed 
up to 50-metres from 3 days (RR 35, 95% 22·5—54·6) to 6 days (RR 28·2, 95% CI 16·6-48).51 
This suggests a spatiotemporal window extending to 7 days and a 50 meters around the primary 
case.51  
Shared risk factors and behaviors among neighboring households may underpin the risk 
presented by the spatiotemporal windows. In Dhaka, type of water source, distance to water 
source, intermittent water supply, sharing a latrine, and soap availability were clustered among 
case-households and neighboring households, with clustering of water sources extending to 400-
metres.50 Prospective studies in Dhaka, Bangladesh estimated a high risk of household 
transmission, via cross-contaminated water or food.52-54 Infection through household 
transmission has been measured as 2-4 fold higher than through community sources.52 In another 
study, 49% of household contacts developed diarrhea and 21% were culture-positive during a 21-
day study period.54 A meta-analysis also showed a 3-fold increase in the odds of infection among 
household contacts of a suspected case (OR 2·9, 95% CI 1·6—5·3).55  
 
CATI implementation and evaluation  
We identified CATI use during epidemics in Cameroon (Douala), Haiti (2010-1 and 2013-7), 
Bangladesh (Dhaka), South Sudan (Juba), Nepal (Kathmandu Valley), Yemen, and DRC 
(Kinshasa) (Table 3).56-70 CATI was implemented to address incident case-clusters within 1-2 
weeks of cholera detection in Douala, Haiti (2010), and Kathmandu and 1-4 weeks in 
Kinshasa.61,63,67,69,70 In Haiti, within two weeks of detection, CATI provided early detection of 
cholera-related events to inform rapid response.69 This was followed by an intensive program 
where case-households and their 50-100-metre radius were targeted.65,66 In Kinshasa, CATI was 
used to target case-households in a 500-m radius.70After the 2015 earthquake in Nepal, CATI 
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was integrated into cholera preparedness planning using existing RRTs.67 In Yemen, to direct 
resources 10-months into a large national epidemic, WASH and health interventions were 
organized by RRTs to deliver CATI.65 In Juba, CATI was used at the end of a mass vaccination 
campaign to reduce transmission around sporadic cases.64  
Trigger events 
Triggering occurred after cases sought care for diarrhea at health facilities. In Douala and 
Kinshasa, suspect cases were exhaustively responded to.61,63,70 CATIs in Juba, Kathmandu, and 
Dhaka were launched for cases testing positive by rapid diagnostic test (RDT) or culture 
(Nepal).60,64,67 In Haiti and Yemen, case-clusters with above-threshold levels of suspect cases 
and deaths during the previous 7 days were responded to.65,66 
Interventions 
The most widely used strategy was comprehensive WASH including POUWT and safe storage 
(at the household-level), and water treatment and hygiene promotion (at the community level).61-
63,65,67,70 In Haiti and Yemen, CATI focused on WASH interventions to improve hygiene and 
access to safe water in remote and rural areas.65,66 In Kinshasa, emphasis was also placed on 
increasing community-level water supply and handwashing stations.70 ACP using doxycycline 
was used in Douala, Haiti, and Kinshasa.61,63,70 In urban Douala and Kinshasa, adjacent 
households were considered at high risk given population density, and therefore ACP with 
WASH was prioritized to act immediately to curtail interpersonal transmission.61,63,70 OCV was 
used in Juba, through leftover stock from a vaccination campaign.64 In Kathmandu, OCV was 
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In Haiti, Kathmandu, and Yemen, radii of 50-100 meters were aimed for (estimated as 10-20 
households in Haiti).65-67 Directly-adjacent households in Douala and the neighborhoods of cases 
in Juba defined ring sizes.61,63,64 The intended timing of initial household visit after case-
presentation ranged from 24 hours (Douala, Haiti, Yemen) to 48 hours (Haiti, Kathmandu).61-
63,65,67  Most reports did not describe the duration CATI activities. In Kinshasa, a large 500-metre 
ring was targeted over 14 days by dividing the ring into grid squares of 20-30 households.70  
Coverage of alerts and intervention delays 
Among city-wide epidemics, coverage of alerts ranged from 54% of culture-confirmed cases in 
Kathmandu, 82% of RDT+ cases in Juba, health zones covering 78% of the caseload in 
Kinshasa, to >99% of suspected cases in Douala.61,63,64,67,70 Among large epidemics, coverage of 
alerts varied (39% of small-scale outbreaks in Haiti; 83% of confirmed and 32% of suspected 
cases in Yemen).65,66 In Kathmandu, a survey 6-8 months post-implementation estimated that 
30% of catchment households received messaging.67 In Juba, 51% (95% CI 42—60) of surveyed 
respondents reported vaccination through CATI.64 OCV was not restricted to persons living in 
the neighborhood, and surveys may have biased toward lower coverage. 
Mean delays from case-presentation to implementation of 3·9 days (range, 1—9) 
occurred in Kathmandu, with 2 days attributed to culture-confirmation.67 In Juba, a mean delay 
of 3·4 days (range, 1—6) reflected the time for RDT enrichment and organization of OCV.64,91 
Delays also reflected challenges in reaching communities. In Haiti, 75% of home visits were 
completed within the first 24 hours of case presentation and 85% within 48 hours in 2018.65 
Given extremely-restricted humanitarian access in Yemen, a relatively high proportion of home 
visits were made within 48 hours (46%) and 72 hours (69%).65  
Costing 
Costing was rarely reported. Yemen and Haiti documented costs of US$3000 USD and 
US$10234 per team per month.65 In Dhaka, the cost per-household was US$45.50 and cost per-
case averted was US$227.50.60 
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Table 4: Evaluations of CATI 



















HH: POUWT, storage, 
ACP, HHS, HP 
 




▪ 456 outbreaks 
 
39% of outbreaks 
responded to 
▪ >7 days (17%, 
30/176) 
▪ 3-7 days (14·2%, 
25/176) 
▪ 2 days (17·6%, 
31/176) 
▪ ≤1 day (51·1% 
90/176) 
NR ▪ Quasi-experimental 
study with groups 
stratified by response 
promptness   
▪ Outcomes for 61% of 
the outbreaks not 
responded to not 
discussed 
▪ Use of ACP could not 
be recorded and are 
unmeasured 
▪ A first complete prompt CATI (≤1 day 
after outbreak onset) reduced 
accumulated cases by 74% (95% CI 
58—84), and outbreak duration by 
64% (95% CI 42—78), as compared 
to a first complete delayed CATI (>7 
days after outbreak onset) 
▪ The temporal response was consistent 









confirmed cases and 
84 controls (RCT) 
100% of enrolled 
cases (RCT) 
None (as per study 
protocol) 
NR ▪ Individual RCT 
▪ Intensive 7-day home 
visit protocol  
▪ Large proportion of 
household contacts 
were not enrolled 
(27%) though did not 
differ by arm 
 
Among HH contacts in intervention arm: 
▪ Reduction in symptomatic infections 
(OR=0, 95% CI 0—0·62) (no 
symptomatic infections were found 
among intervention contacts) 
▪ Reduction in culture-confirmed cases 
(OR=0·5, 95% CI 0·21—1·18) 
▪ No Cholerae in drinking water (OR=0, 
95% CI 0—1·08) 
6-12 months post-intervention: 
▪ Increase in handwashing with soap at 
a key time during structured 
observation (OR 4·71, 95% CI 2·61—
8·49) 
▪ Reduction in households in the very 
high-risk category for stored drinking 












99% of suspected 
cases 
NR NR ▪ Post-hoc analysis 
▪ Observational study 
▪ No comparison group 
▪ Proportion of contacts in among all 
suspected cases decreased from 30% 
in first month to <1% in last month 





HH: POUWT, storage, 
ACP, HHS, HP 
NR Health zones 
where 78% of 
cases originated 
NR NR ▪ Post-hoc analysis 
▪ Observational study 
▪ No comparison group 
▪ Use of ACP was 
unmeasured 
▪ Weekly case count decreased by 71% 
and 83% 4 weeks and 8 weeks after 






HP, storage, bladders 













Study design and limitations  
Juba,  
South Sudan, 201564 
 
Community: OCV, 
POUWT, soap, HP 
14 RDT+ suspected 
cases (or 17 
identified) 
82% of RDT+ 
suspected cases 




▪ Post-hoc analysis 
▪ Denominator for coverage indicator unclear given CATI was 




HH: POUWT, safe 
storage, intensive HP; 
Community: WCT, HP 
169 culture-
confirmed cases 
54% of RDT+ 
suspected cases 
3·9 days (range 1-9 
days); 1·7 days after 
culture result 





communities   
▪ Post-hoc analysis of delay between detection and implementation 
▪ Coverage surveys conducted 1 year after CATI, increasing recall bias 
Yemen, 2017-65 
 






NR 83% of 
confirmed cases;  
 
32% of suspected 
cases 
In 2018, 3% of suspected 
case responded to within 
24h; 43% within 24-48h; 
23% within 48-72h.  
NR ▪ Post-hoc only analysis 
▪ No impact measured 
▪ Surveillance data used is difficult to interpret as it includes a high 
proportion of non-cholera diarrhea 
NR=not reported, HH=household, ACP=antibiotic chemoprophylaxis, POUWT=point of use water treatment, HHS=household spraying, HP=hygiene promotion 
using trained personnel, WCT=water collection treatment, OCV=oral cholera vaccination 
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Impact on the reduction of transmission 
The potential impact of CATI on the reduction of transmission was investigated using a 
computational model of an epidemic in N’Djamena that compared CATI in a spatiotemporal 
radius of 100-metres with uncontrolled transmission.57 OCV, POUWT, and ACP, delivered 
individually through CATI, were projected to shorten the epidemic duration by 68% (IQR 62% 
to 72%), 21% (IQR 7% to 35%), 2% (IQR −11% to 8%).57 
Four evaluations with effect estimates were conducted in Douala, Kinshasa, Dhaka, and 
Haiti (2015-2017)60-63,70; two designs60,62 were controlled (Table 4). In Douala, where ACP and 
well chlorination were used, a post-hoc analysis of surveillance data without a comparison group 
demonstrated a decrease in secondary attack rates among contacts of suspected cases from 30% 
during the first month to <1% in the last month of the epidemic.61,63 This suggested that ACP 
was effective in reducing the bacterial load among household contacts. The epidemic continued 
with a similar dissemination pattern to a previous outbreak, suggesting that the intervention 
package could not interrupt environmentally-mediated transmission (noting that well 
chlorination is ineffective).36,63 In Kinshasa, using intensive WASH in the household and the 
community and ACP for household contacts, caseloads decreased by 71% and 83%, 4-weeks and 
8-weeks after the outbreak peak.70 While an uncontrolled study, the staggered implementation 
across sites over 4 weeks demonstrated similar reductions across outbreaks.  
An RCT in Dhaka in which households of RDT+ and culture-confirmed cases were 
randomized to an intensive hygiene intervention, demonstrated a reduction in incidence of 
symptomatic infection [OR 0, 95% CI 0—0·62; no events in intervention arm] and a non-
significant reduction in asymptomatic and symptomatic cases [OR 0·5, 95% CI 0·21—1·18] 
among household contacts.60 Participants’ handwashing self-efficacy was enabled by instruction, 
equipment, POUWT and soap.58 At 6-12 months, hand-washing was sustained and stored water 
had a below-threshold coliform count.59,68 Contaminated household water was a risk factor for 
infection.56 It is unlikely that this intensive program would be realistic for outbreak response. 
In Centre Department, Haiti, CATI’s impact on epidemic duration and caseload was 
evaluated using a quasi-experimental design with groups stratified by the promptness of 
response.62,66 238 (53%) of 452 outbreaks (with ≥1 positive culture or severely-dehydrated case) 
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were prioritized for response based on severity (POUWT, hygiene promotion, hygiene kits, ACP 
[non-systematically], community water treatment). Compared to CATI ≥7 days after outbreak 
onset, CATI <7 days after outbreak onset reduced attack rates by 76% (95% CI 59—86), and 
outbreak duration by 61% (95% CI 41—75). A relationship with the timeliness of response 
suggested that CATI was effective. Reductions in attack rates (63% [95% CI 24—82] versus 
39% [95% CI -38—73]) and duration (74% [95% CI 43-88] versus 58% [95% CI 11—80]) 
increased significantly if ACP was used, demonstrating the intervention-specific effect of ACP. 
However, the inconsistency in use of ACP and other interventions potentially reduced overall 
impact. The program may not have been operationally efficient; most CATI responses were 
triggered by syndromically-diagnosed cases, which resulted in 3,887 CATI responses, of which 
16% were conducted during an outbreak. 
Conceptual framework 
Each intervention was placed along a timeline which starts with the identification of the primary 
case(s), and follows the spatiotemporal radius of 100-metres over 7 days (Figure 1). The highest 
risk of transmission occurs among household members, followed by adjacent households, and 
households in the ring. In red, fast-acting interventions within the case-household reduce 
transmission (e.g., ACP, POUWT facilitated with safe storage, soap, and hygiene promotion). 
ACP for adjacent households (in orange) promptly reduces risk, considering that case-
households are small units wherein few persons are exposed to the primary case, and risk of 
exposure may be high in the community.92 POUWT, storage, soap (or hygiene kits) rapidly 
facilitate reduced transmission in adjacent households. Single-dose OCV implemented in the ring 
over several days focally reduces spatial transmission, while mass vaccination campaigns can be 
prepared should the outbreak expand. Hygiene promotion facilitated by CHWs is undertaken to 
promote uptake and extend CATI activities.  
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Figure 1. Conceptual framework for CATI delivered within a 100-meter radius and 7 days (Figure modified from Roskosky et al, 2019) 
HH=household, ACP=antibiotic chemoprophylaxis, POUWT=point of use water treatment, HP=hygiene promotion using community health workers (CHW), 
OCV=oral cholera vaccination (single-dose). Red pertains to the primary case-household, orange to the immediately-adjacent households, and yellow to the 





Our analysis integrates multiple lines of evidence on the effective implementation of CATI 
during cholera epidemics. We found moderate evidence that ACP, intensive hygiene promotion, 
POUWT, and single-dose OCV can rapidly limit transmission. Four studies indicated a high-risk 
spatiotemporal ring of 50-100 metres over 7 days in urban and rural contexts, likely related to 
intense household transmission and shared risk factors among households. This specifies an 
implementation radius which has been used in Haiti, Nepal, and Yemen. CATI’s ability to 
address >80% of epidemic alerts suggests feasibility across settings.61,63-65 While additional 
rigorous evaluation is needed, two controlled studies in Bangladesh and Haiti respectively 
showed a reduction in household transmission when targeting case-households, and in duration 
and size of case-clusters when targeting radii.60,62 This reflects the findings of mathematical 
models where CATI57 using OCV or similar OCV-targeting strategies93 demonstrated reduced 
outbreak size and duration. 
CATI’s effectiveness in reducing local transmission depends on the ability of combined 
interventions to impact both transmission routes with a rapid onset of protection and an adequate 
radius of implementation. Rapidly-acting interventions like ACP and household WASH are a 
priority. ACP can protect uninfected and infected hosts, and was demonstrated to increase the 
impact of a WASH-focused CATI.62 Hand-washing and hygienic behaviours underlie household 
transmission.38,40 Single-dose OCV should be strongly considered for CATI, as it is the only 
intervention to incite extended protection, within a week, and is as effective as two doses over a 
two month to one year period.24,27 On the horizon, a live attenuated OCV has demonstrated a 24-
hour onset to protection in an infant rabbit model.94 While the current evidence supports ring 
sizes of approximately 100-m, practical evaluation of the feasibility of implementation should be 
undertaken, particularly in urban contexts. The potential benefits of conducting CATI in a 
densely-packed population, in terms of potential impact and resource savings, must be 
considered alongside the feasibility of achieving coverage within a one-week period. 
 The rapid detection of case-clusters through sensitive surveillance and diagnostic 
specificity using enriched RDTs to select for cholera are an essential foundation for CATI which 
requires simultaneous field support.91,95 With mean delays of 4 days involving confirmation 
(Kathmandu) and RDT enrichment and OCV implementation (Juba), CATI would not be fast 
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enough to interrupt the first generation of transmission, even if the onset of protection was 
immediate.64,67 National preparedness and control plans should proactively integrate 
epidemiological scenarios for use of CATI to organize support for surveillance and interventions. 
Global preparedness policy requires consideration of CATI’s particular use of interventions. The 
global OCV stockpile does not address provision for CATI, though vaccine supply is increasing 
and disbursing small batches to countries before the cholera season should be attainable.29,72 The 
GTFCC supports ACP for closed settings (e.g. prisons) but requires more evidence to inform 
guidance for community contacts.71  
Two related areas for development are to establish costs and models for scale-up. 
Monthly costs for national coverage of CATI in Haiti and Yemen (without OCV) were within 
range of a one-dose OCV campaign in Lusaka (USD$1M).32,65 However, these costs reflect 
national, UNICEF-supported responses, which may exceed costs of smaller outbreaks and for 
national or non-governmental organizations. Maintaining implementation during a growing 
epidemic is challenging and resource-intensive. Few CATI experiences used CHW networks or 
oral rehydration points (ORP) whereas they provide existing infrastructure to engage 
communities and continue the delivery of CATI interventions, particularly where humanitarian 
access is poor.67,96   
Limitations and future research 
CATI strategies have focused on household WASH, with minimal integration of ACP and OCV. 
Prospective studies should evaluate the impact of packages of interventions which combine 
immediate impacts of interventions with longer-term protection by OCV. Given the logistical 
and ethical difficulties in conducting RCTs during epidemics, quasi-experimental designs with 
mathematical modelling and costing should be considered.57,97 Low-level transmission during the 
dry season may be able to contained by CATI, to prevent V. cholerae from seeding and 
proliferating during the rainy season.98,99 Such opportunistic timing could be evaluated, given the 
difficulties in maintaining CATI during a large epidemic. Finally, the effectiveness of ACP for 
cholera requires evidence that considers different drug classes and antibiotic resistance, similar 
to current investigations of ciprofloxacin use for ACP during meningococcal meningitis 
epidemics.92,100 While increases in macrolide resistance occurred during a large trial of 
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azithromycin to reduce child mortality in Niger, the comparatively small volumes distributed for 
CATI may carry less resistance risk.101,102  
CONCLUSION 
To both contain an outbreak and protect against ongoing risk of infection, we consider the core 
components of effective CATI to be, sensitive surveillance and local RDT capacity; integration 
of rapidly-protecting interventions in adjacent households (ACP, POUWT, hygiene promotion) 
and extended-protection interventions in the ring (OCV); and resources to mount implementation 
in 50-100-metre rings. Delays in cholera detection and response due to weak surveillance, slow 
reactivity of actors, insufficient preparedness, and conflict will continue to undermine cholera 
response.34,80,84,103 CATI as a new model for cholera response can purposively address these 
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